Acurx Pharmaceuticals Inc (ACXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 2,670 | 2,627 | 4,642 | 4,071 | 1,474 |
| Operating Income | -2,670 | -2,627 | -4,642 | -4,071 | -1,474 |
| Other Income | 0 | 0 | 0 | 67 | 0 |
| Pre-tax Income | -2,670 | -2,627 | -4,642 | -4,004 | -1,474 |
| Net Income Continuous | -2,670 | -2,627 | -4,642 | -4,004 | -1,474 |
| Net Income | $-2,670 | $-2,627 | $-4,642 | $-4,004 | $-1,474 |
| EPS Basic Total Ops | -0.26 | -0.25 | -0.46 | -0.57 | -0.21 |
| EPS Basic Continuous Ops | -0.26 | -0.25 | -0.46 | -0.57 | -0.21 |
| EPS Diluted Total Ops | -0.26 | -0.25 | -0.46 | -0.57 | -0.21 |
| EPS Diluted Continuous Ops | -0.26 | -0.25 | -0.46 | -0.57 | -0.21 |
| EBITDA(a) | $-2,670 | $-2,627 | $-4,642 | $-4,071 | $-1,474 |